(Q39448629)

12 September 2017

title

Inhibition of cortactin and SIRT1 expression attenuates migration and invasion of prostate cancer DU145 cells (English)

1 reference

12 September 2017

1 reference

Keita Nakane

1

1 reference

12 September 2017

Yasunori Fujita

2

1 reference

12 September 2017

Riyako Terazawa

3

1 reference

12 September 2017

Yuko Atsumi

4

1 reference

12 September 2017

Taku Kato

5

1 reference

12 September 2017

Yoshinori Nozawa

6

1 reference

12 September 2017

Takashi Deguchi

7

1 reference

12 September 2017

Masafumi Ito

8

1 reference

12 September 2017

publication date

3 November 2011

1 reference

International Journal of Urology

12 September 2017

published in

1 reference

12 September 2017

volume

19

1 reference

12 September 2017

issue

1

1 reference

12 September 2017

page(s)

71-79

1 reference

Identification and characterization of a novel cytoskeleton-associated pp60src substrate

12 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2011.02888.X

Cortactin in tumor invasiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2011.02888.X

Aberrant expression of cortactin in head and neck squamous cell carcinoma cells is associated with enhanced cell proliferation and resistance to the epidermal growth factor receptor inhibitor gefitinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2011.02888.X

Amplification and overexpression of CTTN (EMS1) contribute to the metastasis of esophageal squamous cell carcinoma by promoting cell migration and anoikis resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2011.02888.X

Amplification and overexpression of the EMS 1 oncogene, a possible prognostic marker, in human hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2011.02888.X

Dominant expression of 85-kDa form of cortactin in colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2011.02888.X

Sirtuins in mammals: insights into their biological function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2011.02888.X

The critical role of the class III histone deacetylase SIRT1 in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2011.02888.X

Composition and histone substrates of polycomb repressive group complexes change during cellular differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2011.02888.X

SIRT1 is significantly elevated in mouse and human prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2011.02888.X

Aberrant cytoplasm localization and protein stability of SIRT1 is regulated by PI3K/IGF-1R signaling in human cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2011.02888.X

A role for SIRT1 in cell growth and chemoresistance in prostate cancer PC3 and DU145 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2011.02888.X

MiR-148a attenuates paclitaxel resistance of hormone-refractory, drug-resistant prostate cancer PC3 cells by regulating MSK1 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2011.02888.X

Strong expression of a longevity-related protein, SIRT1, in Bowen's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2011.02888.X

Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2011.02888.X

Negative control of p53 by Sir2alpha promotes cell survival under stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2011.02888.X

Nucleocytoplasmic shuttling of the NAD+-dependent histone deacetylase SIRT1

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2011.02888.X

Role of sirtuin histone deacetylase SIRT1 in prostate cancer. A target for prostate cancer management via its inhibition?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2011.02888.X

Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2011.02888.X

Isolation of a human prostate carcinoma cell line (DU 145)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2011.02888.X

RNA interference-directed knockdown of urokinase plasminogen activator and urokinase plasminogen activator receptor inhibits prostate cancer cell invasion, survival, and tumorigenicity in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2011.02888.X

Gas6 induces proliferation in prostate carcinoma cell lines expressing the Axl receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2011.02888.X

Activation of Arp2/3 complex-mediated actin polymerization by cortactin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2011.02888.X

A new role for cortactin in invadopodia: regulation of protease secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2011.02888.X

Dynamic interactions of cortactin and membrane type 1 matrix metalloproteinase at invadopodia: defining the stages of invadopodia formation and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2011.02888.X

Cortactin is an essential regulator of matrix metalloproteinase secretion and extracellular matrix degradation in invadopodia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2011.02888.X

10.1111/J.1442-2042.2011.02888.X

21 January 2018

Identifiers

DOI

1 reference

12 September 2017

1 reference